Enfermedades neurodegenerativas: desarrollo de terapias
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Bañón S, Rosillo M, Gómez A, Pérez-Elias MJ, Moreno S, Casado JL.
Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients
Endocrine . 49(2): 528-537. Nº de citas: 16
-
Perucho J, Gonzalo-Gobernado R, Bazan E, Casarejos MJ, Jiménez-Escrig A, Asensio MJ, Herranz AS.
Optimal excitation and emission wavelengths to analyze amino acids and optimize neurotransmitters quantification using precolumn OPA-derivatization by HPLC
Amino Acids . 47(5): 963-973. Nº de citas: 33
-
Manso L, Moreno F, Márquez R, Castelo B, Arcediano A, Arroyo M, Ballesteros AI, Calvo I, Echarri MJ, Enrech S, Gómez A, González Del Val R, López-Miranda E, Martín-Angulo M, Martínez-Jañez N, Olier C, Zamora P.
Use of bevacizumab as a first-line treatment for metastatic breast cancer
Current Oncology . 22(2): 51-60. Nº de citas: 14
-
Morales P, Blasco-Benito S, Andradas C, Gómez-Cañas M, Flores JM, Goya P, Fernández-Ruiz J, Sánchez C, Jagerovic N.
Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against Triple-Negative Breast Cancer
JOURNAL OF MEDICINAL CHEMISTRY . 58(5): 2256-2264. Nº de citas: 26
-
García MC, Cinquina V, Palomo-Garo C, Rábano A, Fernández-Ruiz J.
Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson's disease
NEUROSCIENCE LETTERS . 587: 1-4. Nº de citas: 61
-
Fernández-Ruiz J, Romero J, Ramos JA.
Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
Handbook of experimental pharmacology . 231: 233-259.
-
Valdeolivas S, Navarrete C, Cantarero I, Bellido ML, Muñoz E, Sagredo O.
Neuroprotective Properties of Cannabigerol in Huntington's Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
Neurotherapeutics . 12(1): 185-199. Nº de citas: 67
-
Ooms M, Rietjens R, Rangarajan JR, Vunckx K, Valdeolivas S, Maes F, Himmelreich U, Fernandez-Ruiz J, Bormans G, Van Laere K, Casteels C.
Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice
NEUROBIOLOGY OF AGING . 35(12): 2858-2869. Nº de citas: 24
-
Fernandes VS, Ribeiro AS, Martínez P, López-Oliva ME, Barahona MV, Orensanz LM, Martínez-Sáenz A, Recio P, Benedito S, Bustamante S, García-Sacristán A, Prieto D, Hernández M.
Hydrogen Sulfide Plays a Key Role in the Inhibitory Neurotransmission to the Pig Intravesical Ureter
Plos One . 9(11): . Nº de citas: 19
-
Calatrava-Ferreras L, Gonzalo-Gobernado R, Reimers D, Herranz AS, Jiménez-Escrig A, Díaz-Gil JJ, Casarejos MJ, Montero-Vega MT, Bazán E.
Neuroprotective Role of Liver Growth Factor ``LGF'' in an Experimental Model of Cerebellar Ataxia
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 15(10): 19056-19073. Nº de citas: 4
-
Casarejos MJ, Perucho J, López-Sendón JL, García de Yébenes J, Bettencourt C, Gómez A, Ruiz C, Heutink P, Rizzu P, Mena MA.
Trehalose Improves Human Fibroblast Deficits in a New CHIP-Mutation Related Ataxia
Plos One . 9(9): . Nº de citas: 21
-
Moreno-Martet M, Espejo-Porras F, Fernández-Ruiz J, de Lago E.
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1(G93A) Transgenic Mice and Evaluation of a Sativex (R)-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
CNS NEUROSCIENCE & THERAPEUTICS . 20(9): 809-815. Nº de citas: 37
-
Moreno E, Andradas C, Medrano M, Caffarel MM, Pérez-Gómez E, Blasco-Benito S, Gómez-Cañas M, Pazos MR, Irving AJ, Lluís C, Canela EI, Fernández-Ruiz J, Guzmán M, McCormick PJ, Sánchez C.
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
JOURNAL OF BIOLOGICAL CHEMISTRY . 289(32): 21960-21972. Nº de citas: 71
-
Chiarlone A, Bellocchio L, Blázquez C, Resel E, Soria-Gómez E, Cannich A, Ferrero JJ, Sagredo O, Benito C, Romero J, Sánchez-Prieto J, Lutz B, Fernández-Ruiz J, Galve-Roperh I, Guzmán M.
A restricted population of CB1 cannabinoid receptors with neuroprotective activity
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA . 111(22): 8257-8262. Nº de citas: 109
-
Ribeiro AS, Fernandes VS, Martínez MP, Martínez-Sáenz A, Pazos MR, Orensanz LM, Recio P, Bustamante S, Carballido J, García-Sacristán A, Prieto D, Hernández M.
Neuronal and non-neuronal bradykinin receptors are involved in the contraction and/or relaxation to the pig bladder neck smooth muscle
NEUROUROLOGY AND URODYNAMICS . 33(5): 558-565. Nº de citas: 3
-
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D.
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Epilepsia . 55(6): 791-802. Nº de citas: 502
-
Rodríguez-Cueto C, Benito C, Fernández-Ruiz J, Romero J, Hernández-Gálvez M, Gómez-Ruiz M.
Changes in CB1 and CB2 receptors in the post- mortem cerebellum of humans affected by spinocerebellar ataxias
BRITISH JOURNAL OF PHARMACOLOGY . 171(6, SI): 1472-1489. Nº de citas: 39
-
Fernandez-Estevez MA, Casarejos MJ, López Sendon J, Garcia Caldentey J, Ruiz C, Gomez A, Perucho J, de Yebenes JG, Mena MA.
Trehalose Reverses Cell Malfunction in Fibroblasts from Normal and Huntington's Disease Patients Caused by Proteosome Inhibition
Plos One . 9(2): . Nº de citas: 43